Generic Name and Formulations:
Ciprofloxacin 6% (60mg/mL); otic susp; preservative-free.
Indications for OTIPRIO:
Bilateral otitis media with effusion undergoing tympanostomy tube placement. Acute otitis externa due to P. aeruginosa and S. aureus.
Adults and Children:
<6mos: not established. For intratympanic or otic administration only. ≥6mos: Otitis media: give as one 0.1mL (6mg) single dose into each affected ear, following suctioning of middle ear effusion. Otitis externa: give as one 0.2mL (12mg) single dose to the external ear canal of each affected ear.
Potential for microbial overgrowth (eg, bacteria, fungi); if infections occur, use alternatives. Pregnancy.
Nasopharyngitis, irritability, ear pruritus, headache, otitis media, ear discomfort.
Single-patient use vial—1mL
Sign Up for Free e-newsletters
- Choice of Breast Reconstruction After Mastectomy Affects Satisfaction, Quality of Life
- Bariatric Surgery Reduced Risk of Some Cancers in Obese Patients
- Carfilzomib Benefits May Outweigh Cardiovascular Risk in Multiple Myeloma
- The Caregivers' Cancer Journey
- Genetic Link Between Depression and Breast Cancer Remains Unclear
- Implementing an Ambulatory Adherence Program May Improve Oral Anticancer Medications Compliance
- Exercise Habits Influence Mortality in Adult Survivors of Childhood Cancer
- Managing Dyspnea With Fentanyl in Patients With Cancer at End of Life
- CALM: A Depression Intervention for Cancer Patients at the End of Life
- High BMI Among Premenopausal Women May Improve Risk for Breast Cancer
- Fertility Preservation in Hodgkin's Lymphoma Patients That Undergo Targeted Molecular Therapies: An Important Step Forward From the Chemotherapy Era
- Survey of ACEP Councilors Reveals NP, PA Staffing Models, Practice Patterns Vary
- Breath Analysis May Be an Effective Diagnostic for Pancreatic Cancer
- Genetic Susceptibility to Pancreatic Cancer Linked to 6 Specific Gene Mutations
- Dinner Hour and Sleep Habits Affect Risk of Breast, Prostate Cancers
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|